"Everything at Advocates is done on a timed basis, so we need to conduct our research efficiently. We don't want to charge clients unnecessarily or write off our time. With Lexis products, we can get more research done each day"
Advocates
Access all documents on Offer to the public
Speed up all aspects of your legal work with tools that help you to work faster and smarter. Win cases, close deals and grow your business鈥揳ll whilst saving time and reducing risk.
For our full legal glossary and more legal research sources, register for a free Lexis+ trial
Eligibility requirements鈥攑remium listing, standard listing, High Growth segment and AIM鈥攑rior to 29 July 2024 A significant restructuring of the UK listing regime came into effect on 29 July 2024 which included the removal of the premium and standard listing segments and the creation of a single listing category for equity shares in commercial companies. The commercial companies category is heavily disclosure-based and sits alongside other listing categories such as the shell companies, secondary listing and closed ended investment fund categories. 聽The UK Listing Rules sourcebook came into force to implement the changes and the Listing Rules sourcebook was revoked. In addition, the London Stock Exchange closed the High Growth segment. For further information see Practice Note: Reform of the UK listing regime鈥攆undamentals.聽This checklist reflects the listing regime prior to 29 July 2024 and has been retained for reference purposes. This checklist compares the eligibility requirements for a former premium listing, a former standard listing, an admission to the former High Growth Segment of the Main Market and admission to trading...
Discover our 1 Checklists on Offer to the public
SAYE鈥攃ompanies which qualify to operate an SAYE scheme This Practice Note covers the following topics: 鈥 the law governing eligibility for companies to operate a save as you earn (SAYE) scheme 鈥 requirements and timing 鈥 the aims of the SAYE legislation 鈥 the legislative requirements for shares under SAYE schemes, including: 鈼 requirement for shares to form part of ordinary share capital 鈼 issues for group companies 鈼 issues for a company which is controlled by another company 鈼 issues for a company which is owned or controlled by a consortium 鈼 issues for a company which is controlled by an unlisted company 鈼 issues for jointly owned companies 鈼 when is a company listed on a recognized stock exchange? 鈼 fully paid up and redeemable shares, and 鈼 requirements if there is more than one class of ordinary shares 鈥 checks and declarations regarding the shares, and 鈥 references to shares in the SAYE scheme For further information on SAYE schemes generally, see Practice Note:...
AIM Rules for Companies鈥攔ules 7, 8 and 9鈥擲pecial conditions for certain applicants This Resource Note outlines the main provisions of Rules 7, 8 and 9 of the AIM Rules for Companies (AIM Rules), which deal with special conditions for certain applicants to AIM. The rules cover lock-ins for new businesses, investing companies and other conditions. This Resource Note highlights relevant materials, commentary and guidance from the London Stock Exchange (LSE), as well as Lexis+庐 UK analysis and resources, to give practical guidance on the interpretation and application of Rules 7 to 9 of the AIM Rules. Materials covered in this Resource Note include: 鈥 the AIM Rules 鈥 the AIM Rules for Nominated Advisers (Nomad Rules) 鈥 Inside AIM, the periodic publication from the AIM Regulation team 鈥 AIM Notices, which are issued periodically, and contain information on AIM regulatory and administrative matters 鈥 Lexis+庐 UK and Lexis庐Library resources. Setting the scene 鈥 Rulebook: AIM Rules for Companies and AIM Note for Investing Companies 鈥 What it covers: Rule...
Discover our 24 Practice Notes on Offer to the public
Agreement among underwriters (US IPO) Agreement Among Underwriters (US IPO) [insert number] Shares (plus [insert number] Shares to cover over allotments, if any) [COMPANY NAME] Common Stock [insert date], 20[insert year] [Insert name of party] [Insert name of party] As Representatives of the Several Underwriters c/o [Insert name of party] [Insert name of party] [Insert name of party] Re: Public Offering of Common Stock of [COMPANY NAME] Dear [insert text]: We wish to confirm as follows our agreement with you with respect to the purchase, from [insert name of corporate entity], a [insert nature of corporate entity] corporation (the Company), of an aggregate of [insert number] shares (the Firm Shares) of the Company's Common Stock, par value $[insert number] per share (the Common Stock), as well as with respect to the purchase any of the [insert number] shares (the Optional Shares) of Common Stock which the Underwriters (as hereinafter defined) shall have determined to purchase from the Company pursuant to Section [insert section number]...
Placing letter鈥擜IM [ON THE LETTERHEAD OF THE PLACING AGENT] Application has been made for the whole of the issued and to be issued ordinary share capital of the Company to be admitted to trading on AIM. It is expected that Admission will become effective and that dealings in the Ordinary Shares will commence on AIM on [insert expected date of admission to AIM]. No liability whatsoever is accepted by [insert name of Placing Agent] for the accuracy of any information or opinions contained in the Admission Document (as defined below), for which [insert name of Placing Agent] is not responsible, or for the omission of any material information from the Admission Document. Persons receiving this document should note that, in connection with the Placing (as defined below) and Admission, [insert name of PLACING AGENT] is acting exclusively for the Company and no-one else and will not be responsible to anyone other than the Company for providing the protections afforded to its customers or for advising any other...
Dive into our 4 Precedents related to Offer to the public
What is meant by the phrase 鈥榥egotiable on the capital market鈥 in the definition of 鈥榯ransferable securities鈥 for the purposes of determining whether a prospectus is needed for a public offer of securities? Practice Note: The Prospectus Directive and ECM鈥攚hen is a prospectus required? [Archived] provides guidance on the definition of 鈥榯ransferable securities鈥 in section 102A of the Financial Services and Markets Act 2000 (FSMA 2000). FSMA 2000, s 102A defines 鈥榯ransferable securities鈥 as anything which is a transferable security for the purposes of the Markets in Financial Instruments Directive 2014/65/EU (MiFID) (other than money-market instruments for the purposes of that directive which have a maturity of less than 12 months). The definition of 鈥榯ransferable securities鈥 in Article聽4(44) of Directive (2014/65/EU) reads: 鈥樷渢ransferable securities鈥 means those classes of securities which are negotiable on the capital market, with the exception of instruments of payment, such as: (a) shares in companies and other securities equivalent to shares in companies, partnerships or other entities, and depositary receipts in respect of shares;...
What exemptions are in force under the Prospectus Regulation from the requirement to publish a prospectus for small offers of securities to the public in the EU where the consideration is below a certain limit? The Prospectus Regulation, Regulation (EU) 2017/1129 will apply in the EU from 21 July 2019 but some provisions apply from an earlier date including Articles 1(3) and 3(2) which applied from 21 July 2018. For more information, see Practice Note: The Prospectus Directive and ECM鈥攚hen is a prospectus required? [Archived] Article 1(3) exempts from the entire scope of the prospectus regime all offers of securities to the public with a total consideration within the EEA of less than 鈧1m, calculated over a period of 12 months. This is an EEA wide exemption and Member States cannot require a prospectus for offers to the public below this threshold. Individual Member States can however impose other disclosure requirements at a national level provided they do not constitute a 鈥榙isproportionate or unnecessary burden鈥. Article 3(2) gives...
See the 18 Q&As about Offer to the public
The European Commission has adopted a Delegated Regulation supplementing Regulation (EU) 2023/1114 (Markets in Cryptoassets Regulation (MiCA)) with regard to regulatory technical standards specifying the information in an application for authorisation to offer asset-referenced tokens to the public or to seek their admission to trading. The Delegated Regulation enters into force on the 20th day following its publication in the OJ. MiCA empowers the Commission to adopt delegated act to further specify the information relating to the content of the application for authorisation to offer to the public or to seek admission to trading of asset-referenced tokens. The Delegated Act specifies information relating to, among other things: 聽the applicant issuer,聽business model, strategy and risk profile, internal control framework and shareholders.
Read the latest 1 News articles on Offer to the public
**Trials are provided to all 桔子视频 content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these 桔子视频 services please email customer service via our online form. Free trials are only available to individuals based in the UK, Ireland and selected UK overseas territories and Caribbean countries. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
0330 161 1234